Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1974-03-01
1976-01-20
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 424 12, A61K 4300, G01T 116, G01T 1167, G21H 502
Patent
active
039339971
ABSTRACT:
Clinically significant concentrations of digoxin can be determined by reacting an unknown amount of digoxin, a known amount of labelled digoxin, and a composite consisting of anti-digoxin antibodies coupled through an intermediate silane to magnetically responsive particles; magnetically separating the immunochemical complexes formed thereby, counting the radioactivity of either the separated products or remaining solution, and relating the count to a standard curve.
REFERENCES:
patent: 3519538 (1970-07-01), Messing et al.
patent: 3652761 (1972-03-01), Weetall
Hersh Leroy S.
Yaverbaum Sidney
Corning Glass Works
Giblin James A.
Janes Jr. Clinton S.
Nucker Christine M.
Padgett Benjamin R.
LandOfFree
Solid phase radioimmunoassay of digoxin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Solid phase radioimmunoassay of digoxin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Solid phase radioimmunoassay of digoxin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1698627